Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel
OTCMKTS:NVZMY

Novozymes A/S Q1 2026 Earnings Report

Novozymes A/S logo
$65.02 -2.41 (-3.57%)
As of 09/25/2026 03:59 PM Eastern
ProfileEarnings HistoryForecast

Novozymes A/S EPS Results

Actual EPS
$0.51
Consensus EPS
$0.82
Beat/Miss
Missed by -$0.31
One Year Ago EPS
N/A

Novozymes A/S Revenue Results

Actual Revenue
$1.31 billion
Expected Revenue
$1.32 billion
Beat/Miss
Missed by -$13.17 million
YoY Revenue Growth
N/A

Novozymes A/S Announcement Details

Quarter
Q1 2026
Date
5/5/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Novozymes A/S' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Conference Call Resources

Novozymes A/S Earnings Headlines

Head-To-Head Survey: CF Industries (NYSE:CF) and Novozymes A/S (OTCMKTS:NVZMY)
September 26 at 4:31 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31052796
Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
August 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4938633-novozymes-a-s-nvzmy-q2-2026-earnings-call-transcript
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
September 26 at 1:00 AM  |  Base Camp Trading (Ad)
Novonesis (Novozymes) B ADR NVZMY
August 5, 2026  |  morningstar.comM
Novozymes AS DRC (NVZMY)
June 24, 2026  |  investing.comhttps://www.investing.com/equities/novozymes-as-news/14
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
May 14, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/look-novozymes-cpse-nsis-b-002910692.html
See More Novozymes A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Novozymes A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novozymes A/S and other key companies, straight to your email.

About Novozymes A/S

Novozymes A/S (OTCMKTS:NVZMY) was a Danish biotechnology company that developed and commercialized enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource use and develop more sustainable products and processes.

The company supplied biological products and related solutions to a range of industries, including food and beverages, household care, agriculture, animal health, bioenergy and industrial manufacturing. Its portfolio included enzymes used in areas such as baking, brewing, dairy production, detergents, textiles, biofuels and technical processing, as well as microbial products for agricultural and other biological applications.

Novozymes was established in 2000 through the demerger of the enzyme activities of Novo Nordisk and was headquartered in Bagsværd, Denmark. It served customers internationally through research, production and commercial operations across multiple regions. In January 2024, Novozymes combined with Chr. Hansen Holding A/S to form Novonesis, a biosolutions company. As a result, Novozymes is primarily of historical interest as a separately listed company, and its former operations are now part of Novonesis.

View Novozymes A/S Profile
Earnings Tools